Infectious disease IVDs
Australia TGA ARTG Registered Device · Biomerieux Australia Pty Ltd · BioFire Diagnostics LLC · Class I · Started November 11, 2022
Good Name: Biomerieux Australia Pty Ltd - Infectious disease IVDs
- Risk Class
- Class I
- Product Type
- IVD
- ARTG Category
- IVD-Export
- Start Date
- November 11, 2022
- Effective Date
- November 11, 2022
- Country
- United States of America
- Address
- 515 Colorow Dr, Salt Lake City, Utah, 84108
IVDs that are intended to be used in testing to provide information about infection with or exposure to infectious agents capable of causing disease, including viruses, bacteria, fungi, parasites and/or prions.
Access comprehensive regulatory information for Infectious disease IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Biomerieux Australia Pty Ltd, manufactured by BioFire Diagnostics LLC in United States of America. The device registration started on November 11, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.